High serum vaspin concentrations in patients with ulcerative colitis

Digestive Diseases and Sciences

Volumn 59, Issue 2, 2014, Pages 315-321

  Morisaki, Tomohito ^a   Takeshima, Fuminao ^a   Fukuda, Hiroko ^a   Matsushima, Kayoko ^a   Akazawa, Yuko ^a   Yamaguchi, Naoyuki ^a   Ohnita, Ken ^a   Isomoto, Hajime ^a   Takeshita, Hiroaki ^a   Sawai, Terumitsu ^a   Fujita, Fumihiko ^a   Nakao, Kazuhiko ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Adipocytokine; Crohn's disease; Inflammatory bowel disease; Ulcerative colitis; Vaspin

Indexed keywords

ACETYLSALICYLIC ACID; INFLIXIMAB; MESALAZINE; VASPIN;

ADIPOSE TISSUE; ADULT; ARTICLE; CROHN DISEASE ACTIVITY INDEX; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY CELL; KRUSKAL WALLIS TEST; LARGE INTESTINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; ULCERATIVE COLITIS; VASPIN BLOOD LEVEL; WILCOXON SIGNED RANKS TEST;

ADIPOSE TISSUE; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SERPINS; UP-REGULATION; YOUNG ADULT;

EID: 84896708431     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2905-5     Document Type: Article

References (22)

1. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-432.
2. Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose most abundant gene transcript 1). Biochem Biophys Res Commun. 1996;221:286-289.
3. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
4. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409:307-312.
5. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science. 2005;307:426-430.
6. Maeda K, Okubo K, Shimomura I, et al. Analysis of an expression profile of genes in the human adipose tissue. Gene. 1997;190:227-235.
7. Sheehan AL, Warren BF, Gear MW, et al. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg. 1992;79:955-958.
8. Desreumaux P, Ernst O, Geboes K, et al. Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology. 1999;117:73-81.
9. Hida K, Wada J, Eguchi J, et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc Natl Acad Sci USA. 2005;102:10610-10615.
10. Valentini L, Wirth EK, Schweizer U, et al. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition. 2009;25:172-181.
11. Nishi Y, Isomoto H, Ueno H, et al. Plasma leptin and ghrelin concentrations in patients with Crohn's disease. World J Gastroenterol. 2005;11:7314-7317.
12. El-Mesallamy HO, Kassem DH, El-Demerdash E, et al. Vaspin and visfatin/Nampt are interesting interrelated adipokines playing a role in the pathogenesis of type 2 diabetes mellitus. Metabolism. 2011;60:63-70.
13. Aktas B, Yilmaz Y, Eren F, et al. Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease. Metabolism. 2011;60:544-549.
14. Ozgen M, Koca SS, Dagli N, et al. Serum adiponectin and vaspin levels in rheumatoid arthritis. Arch Med Res. 2010;41:457-463.
15. Kadoglou NP, Gkontopoulos A, Kapelouzou A, et al. Serum levels of vaspin and visfatin in patients with coronary artery disease-Kozani study. Clin Chim Acta. 2011;412:48-52.
16. Kukla M, Zwirska-Korczala K, Gabriel A, et al. Chemerin, vaspin and insulin resistance in chronic hepatitis C. J Viral Hepat. 2010;17:661-667.
17. Fioravanti A, Simonini G, Cantarini L, et al. Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease. Rheumatol Int. 2012;32:1481-1482.
18. Saalbach A, Vester K, Rall K, et al. Vaspin - a link of obesity and psoriasis? Exp Dermatol. 2012;21:309-312.
19. Auguet T, Quintero Y, Riesco D, et al. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet. 2011;12:60.
20. Klaasen R, Herenius MM, Wijbrandts CA, et al. Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis. Ann Rheum Dis. 2012;71:1510-1516.
21. Lee JA, Park HS, Song YS, et al. Relationship between vaspin gene expression and abdominal fat distribution of Korean women. Endocr J. 2011;58:639-646.
22. Phalitakul S, Okada M, Hara Y, et al. Vaspin prevents TNF-α-induced intracellular adhesion molecule-1 via inhibiting reactive oxygen species-dependent NF-κB and PKCθ activation in cultured rat vascular smooth muscle cells. Pharmacol Res. 2011;64:493-500.